Depixus
Thibaut Roulon is a seasoned investment professional serving as the Senior Investment Director in Life Sciences at Bpifrance since July 2013, where involvement includes managing investments in life science companies at various development stages. Roulon is also a board member for several innovative companies, including Nouscom AG, Depixus, AlgoTherapeutix, ImCheck Therapeutics, NH TherAguix, Step Pharma, and Advicenne Pharma SA, contributing expertise to the development of novel therapies and technologies in cancer treatment and rare diseases. Additionally, Roulon has been self-employed as a fine art black & white film photographer since 2007. Academic qualifications include a Ph.D. in Molecular Biophysics from Pierre and Marie Curie University and a Master's in Engineering/Biotechnology from CentraleSupélec.
This person is not in any teams
This person is not in any offices
Depixus
1 followers
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.